Assignee
FOLDRX PHARMACEUTICALS INC
US·1 granted patent·6 pending applications·5 citations·filing 2005–2008
Top patents by PatentIndex Score
7 records- 0178US7868033B2Compounds, compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfoldingFOLDRX PHARMACEUTICALS INC·Filed 2005·Granted Jan 11, 2011·5 cites·14 claims
- 0244US2010122362A1Cells expressing alpha-synuclein and uses thereforFOLDRX PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 0343US2010331297A1Modulation of protein traffickingFOLDRX PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 0442US2008131907A1Assays for detecting native-state proteins and identifying compounds that modulate the stability of native-state proteinsFOLDRX PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 0541US2010273776A1Inhibition of alpha-synuclein toxicityFOLDRX PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 0640US2010305068A1Compounds and methods for modulating protein traffickingFOLDRX PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 0738US2010004277A1Compounds and methods for modulating protein traffickingFOLDRX PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →